PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
PSTX
Delisted
PSTX was delisted on the 7th of January, 2025.
68 hedge funds and large institutions have $140M invested in Poseida Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
82% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 11
21% more funds holding
Funds holding: 56 → 68 (+12)
Holders
68
Holding in Top 10
2
Calls
$200K
Puts
$56K
Top Buyers
| 1 | +$11.1M | |
| 2 | +$9.36M | |
| 3 | +$7.67M | |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
+$7.31M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$6.53M |
Top Sellers
| 1 | -$3.04M | |
| 2 | -$428K | |
| 3 | -$233K | |
| 4 |
E
Ergoteles
New York
|
-$150K |
| 5 |
Renaissance Technologies
New York
|
-$130K |